Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous mesenchymal stem cell therapy for autoimmune type 1 diabetes mellitus
2009-017228-24Phase 2Terminated
- Sponsor
- Cima Universidad de Navarra
- Start
- Dec 2010
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, single-arm trial of autologous mesenchymal stem cells in diabetes mellitus type 1 (T1D), sponsored by Cima Universidad de Navarra. Primary endpoint: Safety and feasibility of autologous mesenchymal stem cell administration. Started Dec 2010; status: terminated.
02
Drugs
autologous mesenchymal stem cells
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2009-017228-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017228-24.